CFO transition
BioRestorative Therapies, Inc. CFO transition: Anna Skowron to succeed Katharyn Field
BioRestorative Therapies, Inc. reported in a Form 8-K filed September 2, 2026 that Anna Skowron will succeed Katharyn Field as Chief Financial Officer and Treasurer, effective August 27, 2026.
In the filing's words
Effective August 27, 2026, the Board appointed Anna Skowron as the Company’s Chief Financial Officer and Treasurer, serving as the Company’s principal financial officer and principal accounting officer on a non-employee, fractional basis through BPC Consulting Ltd.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | BioRestorative Therapies, Inc. (BRTX) |
|---|---|
| Event | Transition |
| Incoming | Anna Skowron |
| Outgoing | Katharyn Field |
| Title in the filing | Chief Financial Officer and Treasurer |
| Effective | August 27, 2026 |
| 8-K filed | September 2, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Principal, BPC Consulting Ltd. |
| SEC CIK | 0001505497 |
BioRestorative Therapies, Inc. reported this change in a Form 8-K, Item 5.02, filed September 2, 2026. The filing's own words are quoted above.
Other records naming Katharyn Field
1The outgoing officer on this record, matched by name. Career line.
2 months ago· 2026-09-02InterimADBT
Advasa Holdings, Inc. names Grady Ryther interim CFO
Also filed in September 2026
Other CFO moves on the record that month. All moves.
6 weeks ago· 2026-09-30InterimACI
Albertsons Companies, Inc. names Cody Perdue interim CFO
6 weeks ago· 2026-09-30DepartureALDA
Atlantica Inc. discloses CFO departure: Shelley Goff
6 weeks ago· 2026-09-30TransitionCARL
Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein
6 weeks ago· 2026-09-30AppointmentLEVI
Levi Strauss & Co. appoints John Vandemore as CFO
6 weeks ago· 2026-09-30DeparturePTPI
Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein
6 weeks ago· 2026-09-30DepartureTCRX
TScan Therapeutics, Inc. discloses CFO departure: Jason A. Amello
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Anna Skowron? Send a correction with the primary source.